> News > Unisanté and Genknowme join forces to explore the impacts of lifestyle on epigenetics
Unisanté and Genknowme join forces to explore the impacts of lifestyle on epigenetics
Predictives markers in public health are needed
The increased burden of ageing is a major societal, economic and public health challenge. Interest in finding clinical biomarkers that can accurately predict the risk of age-related disease is tremendous. Today’s biomarkers are observational rather than predictive and detect changes only at a later stage.
Recently, a number of human diseases such as cancer, brain disorders or metabolic syndromes have been associated with aberrations in epigenetic processes. Epigenetics refers to changes in gene expression and will dramatically change the way we understand life, health, and medicine.
Genknowme aims to individualize prevention. Our technology has the power to personalize the impact of lifestyle and environment on genes, in order to take preventive actions to improve overall health and longevity. Our comprehensive and predictive health assessment encompassing will be a strong support to promote healthy lifestyle changes.
While together with biological age, genknowme already measures the impact of physical activity, nutrition, alcohol and tobacco consumption; in this project we aim to expand genknowme’s test to customers from different ethnicities; to enlarge our scope with assessment of chronic stress levels and sleep quality and to consolidate our current product by demonstrating the dynamic of epigenetic variation after smoking cessation.